November 10, 2022 — Biosense Webster, Inc., the global leader in cardiac arrhythmia treatment and part of Johnson & ...
Atrial Fibrillation
This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion.
November 10, 2022 — A national study led by UBC researchers at the Centre for Cardiovascular Innovation is shedding ...
November 8, 2022 — iRhythm Technologies, Inc., a leading cardiovascular diagnostics and digital healthcare solutions ...
When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “The ...
November 7, 2022 — iRhythm Technologies, Inc., a leading cardiovascular diagnostics and digital healthcare solutions ...
Nov. 4, 2022 — CathVision, a medical technology company developing innovative electrophysiology solutions to enhance ...
October 31, 2022 — Atrial fibrillation – a form of irregular heartbeat, or arrhythmia – leads to more than 454,000 ...
Apple created a stir when it announced in 2018 that its Apple Watch Series 4 was the first consumer health and fitness ...
October 26, 2022 — A new study from University of Louisville researchers in the Christina Lee Brown Envirome Institute ...
October 25, 2022 — RhythMedix, a leader in remote cardiac monitoring and proprietary arrhythmia detection algorithms ...
October 20, 2022 — A team of Case Western Reserve University scientists has received a four-year, $3.7 million National ...
Improved short-term monitoring methods for patients with stroke risk can increase early detection of atrial fibrillation ...
October 14, 2022 — Biosense Webster, Inc., part of Johnson & Johnson MedTech†, today announced the European launch of ...
At TCT 2022, Deepak Bhatt, MD, MPh, Executive Director of Interventional Cardiovascular Programs, Brigham and Women's ...
September 15, 2022 - Happitech has announced the launch of its FastStart Research app. The Amsterdam-based digital ...
Improved short-term monitoring methods for patients with stroke risk can increase early detection of atrial fibrillation ...
September 14, 2022 — In recognition of Atrial Fibrillation (AFib) Awareness Month, Biosense Webster, Inc., part of ...
September 13, 2022 — Anthos Therapeutics, a clinical-stage biotechnology company developing innovative therapies for ...
September 9, 2 022 — A large-scale international study led by Mount Sinai has yielded the first risk score that can help ...